Latest developments in coumarin-based anticancer agents: mechanism of action and structure–activity relationship studies
Manankar Koley,
Jianlin Han,
Vadim A. Soloshonok
et al.
Abstract:Many researchers all around the world are working on the development of novel anticancer drugs with different mechanisms of action. Coumarin is a highly promising pharmacophore for the development of...
“…These results could be explained by the fact that both, coumarin and chalcone, involve many anticancer mechanisms, including cell cycle arrest, ROS production and apoptosis. [31,[58][59][60] This is also in accordance with those previous reports made by Wang and colleagues [46] who showed a coumarin-chalcone hybrid which efficiently delivered to cells to induce apoptosis through the generation of intracellular ROS in a colorectal carcinoma cell line HCT116. Besides, in other study, Singh and colleagues [61] had demonstrated that a coumarin-chalcone hybrid caused cell cycle arrest at G2/M phase and induced intrinsic caspase-dependent apoptosis mediated by alterations in the cellular levels of Bcl-2 family proteins in cervical cancer cell lines (HeLa and C33A).…”
Section: Antiproliferative Effect Of Hybrid 3c On Human Colorectal Ad...supporting
confidence: 91%
“…A structure-activity relationship (SAR) was rationalized by analyzing the substituents effects and it revealed key differences between those evaluated hybrids 3 a-h (Figure 3 Thereon, different studies have been reported with coumarin and chalcone derivatives, showing the great potential of these two pharmacophores containing methoxy groups, highlighting the properties in different biological models, including colorectal cancer. [31,56] Besides, Alhakamy and colleagues [57] also reported the in vitro anticancer activity of different coumarinchalcone hybrids. They showed two active molecules with methoxy substituents at the 3', 5' positions of the aroyl rings, with IC 50 values in the range of 6.8 μM and 17.2 μM on breast cancer cells (MCF-7 and MDA-MB-231).…”
Section: Effect Of Chalcone-coumarin Hybrids On Cell Viabilitymentioning
confidence: 99%
“…On the other hand, coumarin (1,2-benzopyrone or 2H-1benzopyran-2-one) and its analogues represent a privileged scaffold in drug discovery process that can be used as valuable prototype to design novel compounds with broad-ranging biological activities. [31,32] Particularly, both natural and synthetic coumarin derivatives (Figure 1A, i. e., compounds V-IX) draw attention due to the strong in vitro and in vivo evidence regarding antitumor activity against a wide range of cancer cell lines, [33,34] among them colorectal carcinoma (HCT116, IC 50 = 44.9 � 1.4 μM), colon carcinoma cell line (SW480, IC 50 = 11.18 � 2.16 μM), hepatocellular carcinoma (HepG2, IC 50 = 17.6 � 2.1 μM), human hepatoma cell line (QGY-7701, IC 50 = 14.37 � 9.93 μM), cervical cancer (HeLa cells, IC 50 = 3.8 μM), breast adenocarcinoma cell line (MCF-7, IC 50 < 2 μM), and lung adenocarcinoma (SK-LU-1, IC 50 = 6.9 � 1.6 μM) cell lines. [35][36][37][38] In addition, several studies have determined that generally modulation of caspase-dependent mitochondrial apoptotic pathway is involved in coumarin-mediated cytotoxicity in cancer cells.…”
Eight novel compounds incorporating chalcone and coumarin features, namely chalcone‐coumarin‐ hybrid molecules, were designed, synthetized, and evaluated for their activity against human colorectal carcinoma SW480 cell line. According to the results observed, the hybrid with a 2,3‐dimetoxysubstitution pattern displayed the highest activity at the conditions evaluated, with an IC50 value of 25.18±1.12 μM, being even more active than the reference drug (5‐fluorouracil) and the parental compound (7‐methylcoumarin). In addition, this hybrid compound exhibited significant antiproliferative activity in a time‐ and concentration dependent way, suggesting rather a cytostatic or cytotoxic effect. Moreover, a theoretical drug‐like/pharmacokinetics/toxicological study suggested that the most promising hybrid would have a great chance to advance to further preclinical studies as anti‐cancer therapeutic candidate for oral oncological management. Our study evidently identified the potency of chalcone‐coumarin conjugates, particularly the 2,3‐dimetoxysubstituited molecule to be a prototype drug for further investigations toward novel therapeutics treatments of colorectal cancer.
“…These results could be explained by the fact that both, coumarin and chalcone, involve many anticancer mechanisms, including cell cycle arrest, ROS production and apoptosis. [31,[58][59][60] This is also in accordance with those previous reports made by Wang and colleagues [46] who showed a coumarin-chalcone hybrid which efficiently delivered to cells to induce apoptosis through the generation of intracellular ROS in a colorectal carcinoma cell line HCT116. Besides, in other study, Singh and colleagues [61] had demonstrated that a coumarin-chalcone hybrid caused cell cycle arrest at G2/M phase and induced intrinsic caspase-dependent apoptosis mediated by alterations in the cellular levels of Bcl-2 family proteins in cervical cancer cell lines (HeLa and C33A).…”
Section: Antiproliferative Effect Of Hybrid 3c On Human Colorectal Ad...supporting
confidence: 91%
“…A structure-activity relationship (SAR) was rationalized by analyzing the substituents effects and it revealed key differences between those evaluated hybrids 3 a-h (Figure 3 Thereon, different studies have been reported with coumarin and chalcone derivatives, showing the great potential of these two pharmacophores containing methoxy groups, highlighting the properties in different biological models, including colorectal cancer. [31,56] Besides, Alhakamy and colleagues [57] also reported the in vitro anticancer activity of different coumarinchalcone hybrids. They showed two active molecules with methoxy substituents at the 3', 5' positions of the aroyl rings, with IC 50 values in the range of 6.8 μM and 17.2 μM on breast cancer cells (MCF-7 and MDA-MB-231).…”
Section: Effect Of Chalcone-coumarin Hybrids On Cell Viabilitymentioning
confidence: 99%
“…On the other hand, coumarin (1,2-benzopyrone or 2H-1benzopyran-2-one) and its analogues represent a privileged scaffold in drug discovery process that can be used as valuable prototype to design novel compounds with broad-ranging biological activities. [31,32] Particularly, both natural and synthetic coumarin derivatives (Figure 1A, i. e., compounds V-IX) draw attention due to the strong in vitro and in vivo evidence regarding antitumor activity against a wide range of cancer cell lines, [33,34] among them colorectal carcinoma (HCT116, IC 50 = 44.9 � 1.4 μM), colon carcinoma cell line (SW480, IC 50 = 11.18 � 2.16 μM), hepatocellular carcinoma (HepG2, IC 50 = 17.6 � 2.1 μM), human hepatoma cell line (QGY-7701, IC 50 = 14.37 � 9.93 μM), cervical cancer (HeLa cells, IC 50 = 3.8 μM), breast adenocarcinoma cell line (MCF-7, IC 50 < 2 μM), and lung adenocarcinoma (SK-LU-1, IC 50 = 6.9 � 1.6 μM) cell lines. [35][36][37][38] In addition, several studies have determined that generally modulation of caspase-dependent mitochondrial apoptotic pathway is involved in coumarin-mediated cytotoxicity in cancer cells.…”
Eight novel compounds incorporating chalcone and coumarin features, namely chalcone‐coumarin‐ hybrid molecules, were designed, synthetized, and evaluated for their activity against human colorectal carcinoma SW480 cell line. According to the results observed, the hybrid with a 2,3‐dimetoxysubstitution pattern displayed the highest activity at the conditions evaluated, with an IC50 value of 25.18±1.12 μM, being even more active than the reference drug (5‐fluorouracil) and the parental compound (7‐methylcoumarin). In addition, this hybrid compound exhibited significant antiproliferative activity in a time‐ and concentration dependent way, suggesting rather a cytostatic or cytotoxic effect. Moreover, a theoretical drug‐like/pharmacokinetics/toxicological study suggested that the most promising hybrid would have a great chance to advance to further preclinical studies as anti‐cancer therapeutic candidate for oral oncological management. Our study evidently identified the potency of chalcone‐coumarin conjugates, particularly the 2,3‐dimetoxysubstituited molecule to be a prototype drug for further investigations toward novel therapeutics treatments of colorectal cancer.
“…Compound 4j caused a signicant increase (P < 0.05) in the cell population of the G0/G1-phase (the non-proliferating cell proportion) from 55.71% to 74.14% compared to the control cells, indicating cell cycle arrest and implying that G0/G1 cell cycle arrest is a fundamental mechanism of the anticancer activities of coumarin derivatives, as previously reported. 50 Reciprocally, treatment with 4j showed a meaningful decrease in the cell percentage of the S phase (the DNA synthesis phase) aer 48 h treatment from 17.62% to 9.86% concomitantly with a decrease in the cell percentage in the G2/M phase from 26.67% to 16.00% (Fig. 3A and B), respectively.…”
New pyrazolylindolin-2-one linked coumarin derivatives were designed as dual BRAFV600E/VEGFR-2 inhibitors targeting melanoma cells A375. Docking simulation showed various interactions with the binding residues in BRAFV600E and VEGFR-2 active sites.
“…Coumarins are secondary metabolites of benzopyrones found in several plant genera. According to various studies, these compounds and their derivatives represent an important source of new treatments, especially as antioxidants, antimicrobials, antineoplastics, and anti-inflammatory agents [ 1 , 2 , 3 , 4 , 5 , 6 ]. Coumarins are the major compounds present in Pterocaulon Ell.…”
Coumarins are benzopyrones found in several plant genera, including Pterocaulon (Asteraceae). These compounds represent an important source of new treatments, especially as antimicrobial and antifungal agents. In this study, two coumarin-rich extracts from Pterocaulon balansae using green technologies were obtained through aqueous maceration (AE) and supercritical fluid extraction (SFE). Such extracts were incorporated into nanoemulsions (NAE and NSFE) composed of a medium-chain triglyceride oil core stabilized by phospholipids. The nanoemulsions exhibited droplet sizes between 127 and 162 nm, pH above 5.0, and viscosity of approximately 1.0 cP, properties compatible with the topical route. The coumarins permeation/retention from formulations through ear porcine skin using Franz-type diffusion cells were evaluated. Whatever the extract, coumarins were distributed in skin layers, especially in the dermis in both intact and impaired (tape stripping) skin. In addition, a significant increase in coumarins that reached up to the receptor fluid was observed for impaired skin, with increases of approximately threefold for NAE and fourfold for NSFE. Finally, antifungal activity of nanoemulsions was evaluated according to minimum inhibitory concentrations, and the values were 250 µg/mL for all strains tested. The overall results demonstrated the feasibility of incorporating P. balansae extracts into nanoemulsions and showed a potential alternative for the treatment of sporotrichosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.